Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 68 (2014)
Article
Lưu Thị Bình: Trường Đại học Y Dược Thái Nguyên;
Võ Thị Ngọc Anh: Trường Đại học Y Dược Thái Nguyên;
Published: November 1, 2014
Views: 75
References
1.
1. (2001), “Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)”, JAMA, 285 (19), pp. 2486 - 2497.
2.
2. Hồ Thị Thanh Tâm , Ngô Thế Hoàng, Nguyễn Đức Công(2013), “Đặc điểm của bệnh Goute ở người lớn tuổi tại khoa nội cơ xương khớp bệnh viện Thống Nhất”, Y học TP. Hồ Chí Minh, 17 (Phụ bản số 3), pp. 270-4.
3.
3. Trịnh Kiến Trung, Lê Anh Thư (2010), “Hội chứng chuyển hóa ở bệnh nhân viêm khớp goute”, Nghiên cứu y học, phụ bản số 3, pp. 455-9.
4.
4. Brooks P., Hochberg M., ILAR for, OMERACT (2001), “Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups”, Rheumatology, 40 (8), pp. 896-906.
5.
5. Choi H. K., Atkinson K., Karlson E. W., Curhan G. (2005), “Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study”, Arch Intern Med, 165 (7), pp. 742-8.
6.
6. Choi H. K., Ford E. S., Li C., Curhan G. (2007), “Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey”, Arthritis Rheum, 57 (1), pp. 109-15.
7.
7. Choi Hyon K, Soriano Lucia Cea, Zhang yuqing, Rodríguez Luis A García (2012), Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study, Vol. 344.
8.
8. Fraile J. M., Torres R. J., de Miguel Mendieta E., Martínez P., Lundelin K. J., Vázquez J. J., Puig J. G. (2010), “Metabolic Syndrome Characteristics in Gout Patients”, Nucleosides, Nucleotides and Nucleic Acids, 29 (4-6), pp. 325-329.
9.
9. Surayo Shukurova Khisrav Toirov, Nabijon Hamidov, Dilfuza Jonnazarova, AvicennaTajik (2012), “Age features of metabolic syndrome and cardiovascular disorders in gout”, Arthritis Research & Therapy, 14 (Suppl 1 - P69), pp. 49.
10.
10. Vazquez-Mellado J., Garcia C. G., Vazquez S. G., Medrano G., Ornelas M., Alcocer L., Marquez A., Burgos-Vargas R. (2004), “Metabolic syndrome and ischemic heart disease in gout”, J Clin Rheumatol, 10 (3), pp. 105-9.
11.
11. Whitworth J. A. (2003), “2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension”, J Hypertens, 21 (11), pp. 1983-92.
12.
12. Wong Rose, Davis Aileen M., et al (2010), prevalence of arthritis and rheumatic diseases around the world a growing burden and implications for Health Care Needs.